Integrated Molecular Solutions

Integrated Molecular Solutions (IMS), founded in 2015 and based in San Diego, operates as a specialized service provider in the diagnostics and genomics sector, though its core business is facilitating access to advanced molecular imaging and radiation therapy equipment. The company's primary innovation is a financial and operational partnership model that allows hospitals and treatment centers to deploy state-of-the-art diagnostic and therapeutic systems without large upfront capital investments. By bundling equipment, construction, isotope supply, and billing support into a managed service, IMS addresses key barriers to adoption for technologies like theranostics and advanced radiation oncology. Its model is designed to keep clients technologically current in the rapidly evolving field of precision medicine.

Integrated service and financial platform that provides turnkey access to advanced diagnostic imaging (PET/CT, SPECT/CT) and therapy systems (Linear Accelerators, Radiosurgery, Cyclotrons) via an OpEx-based partnership model. Includes site design/build, isotope supply, and revenue cycle support.

IMS competes with large medical equipment financing arms of OEMs (e.g., GE HealthCare, Siemens), third-party medical equipment leasing companies, and hospital groups that self-finance. Its differentiation is the fully integrated, turnkey service covering construction, isotopes, and operational support, which is less common among pure financiers.